CSP exam questions and answers
5. Which medication would be an appropriate choice for a patient
who has an eGFR <30ml/min?
a. Epclusa (velpatasvir/sofosbuvir)
b. Vosevi (velpatasvir/sofosbuvir/voxilaprevir)
c. Harvoni (ledipasvir/sofosbuvir)
d. Mavyret (glecaprevir/pibrentasvir) - -d. Mavyret
(glecaprevir/pibrentasvir)
-A 30 year old female MS patient states she's thinking about
starting a family. What would you
tell her about the treatment options for MS and pregnancy?
a. Aubagio (teriflunomide) has no pregnancy precautions and
would be a good option for
her.
b. Aubagio (teriflunomide) has been shown to cause birth defects
and can take up to 2
months to be eliminated from the body.
c. Copaxone (glatiramer) is rated category B in pregnancy and a
possible option for
treatment during pregnancy.
d. Betaseron (interferon - -c. Copaxone (glatiramer) is rated
category B in pregnancy and a possible option for
treatment during pregnancy.
-A 45 y/o, 200lb patient is struggling with severe dermatitis and
the provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab) - -d. Dupixent (dupilumab)
-A 45 year old male with pancreatic cancer is given a prescription
for Tarceva (erlotinib). He
, states that he currently smokes about one pack of cigarettes a
day. How should you consult the
patient?
a. Smoking increases Tarceva levels and he will experience more
side effects if he
continues to smoke
b. Smoking decreases Tarceva levels and the medication will be
less effective if he
continues to smoke
c. Tarceva levels aren't affected by tobacco use
d. Smoking while taking Tarceva is contraindicated - -b. Smoking
decreases Tarceva levels and the medication will be less effective
if he
continues to smoke
-A 56 y/o M is diagnosed with metastatic, castration‐resistant
prostate cancer and the provider
asks which oral antiandrogen you recommend. He has a past
medical history including
hypertension and poorly controlled type II diabetes. What is your
recommendation?
a. Zytiga (abiraterone acetate) 1000mg once daily with
prednisone
b. Xtandi (enzalutamide) 160mg once daily with prednisone
c. Xtandi (enzalutamide) 160mg once daily
d. Zytiga (abiraterone acetate) 1000mg once daily - -c. Xtandi
(enzalutamide) 160mg once daily
-A 56 y/o, 140lb patient with psoriasis will be starting Stelara
(ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose
would you recommend?
a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45
mg every 12 weeks
b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90
mg every 12 weeks
c. Infuse 260 mg IV over at least 1 hour as a single dose, followed
8 weeks later with 90 mg
subcutaneously every 8 weeks
5. Which medication would be an appropriate choice for a patient
who has an eGFR <30ml/min?
a. Epclusa (velpatasvir/sofosbuvir)
b. Vosevi (velpatasvir/sofosbuvir/voxilaprevir)
c. Harvoni (ledipasvir/sofosbuvir)
d. Mavyret (glecaprevir/pibrentasvir) - -d. Mavyret
(glecaprevir/pibrentasvir)
-A 30 year old female MS patient states she's thinking about
starting a family. What would you
tell her about the treatment options for MS and pregnancy?
a. Aubagio (teriflunomide) has no pregnancy precautions and
would be a good option for
her.
b. Aubagio (teriflunomide) has been shown to cause birth defects
and can take up to 2
months to be eliminated from the body.
c. Copaxone (glatiramer) is rated category B in pregnancy and a
possible option for
treatment during pregnancy.
d. Betaseron (interferon - -c. Copaxone (glatiramer) is rated
category B in pregnancy and a possible option for
treatment during pregnancy.
-A 45 y/o, 200lb patient is struggling with severe dermatitis and
the provider wants to potentially
start a biologic. Which medication would you recommend?
a. Protopic (tacrolimus)
b. Humira (adalimumab)
c. Stelara (ustekinumab)
d. Dupixent (dupilumab) - -d. Dupixent (dupilumab)
-A 45 year old male with pancreatic cancer is given a prescription
for Tarceva (erlotinib). He
, states that he currently smokes about one pack of cigarettes a
day. How should you consult the
patient?
a. Smoking increases Tarceva levels and he will experience more
side effects if he
continues to smoke
b. Smoking decreases Tarceva levels and the medication will be
less effective if he
continues to smoke
c. Tarceva levels aren't affected by tobacco use
d. Smoking while taking Tarceva is contraindicated - -b. Smoking
decreases Tarceva levels and the medication will be less effective
if he
continues to smoke
-A 56 y/o M is diagnosed with metastatic, castration‐resistant
prostate cancer and the provider
asks which oral antiandrogen you recommend. He has a past
medical history including
hypertension and poorly controlled type II diabetes. What is your
recommendation?
a. Zytiga (abiraterone acetate) 1000mg once daily with
prednisone
b. Xtandi (enzalutamide) 160mg once daily with prednisone
c. Xtandi (enzalutamide) 160mg once daily
d. Zytiga (abiraterone acetate) 1000mg once daily - -c. Xtandi
(enzalutamide) 160mg once daily
-A 56 y/o, 140lb patient with psoriasis will be starting Stelara
(ustekinumab), but the provider
wants to verify the dosing of the medication. What starting dose
would you recommend?
a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45
mg every 12 weeks
b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90
mg every 12 weeks
c. Infuse 260 mg IV over at least 1 hour as a single dose, followed
8 weeks later with 90 mg
subcutaneously every 8 weeks
